Ultra High Field MRI at 8 Tesla of Subacute Hemorrhagic Stroke

[Ultrahigh field MRI in context of neurological diseases]

Ultrahigh field magnetic resonance imaging (UHF-MRI) has recently gained substantial scientific interest. At field strengths of 7 Tesla (T) and higher UHF-MRI provides unprecedented spatial resolution due to an increased signal-to-noise ratio (SNR). The UHF-MRI method has been successfully applied in various neurological disorders. In neuroinflammatory diseases UHF-MRI has already provided a detailed insight into individual pathological disease processes and elucidated differential diagnoses of several disease entities, e.g. multiple sclerosis (MS), neuromyelitis optica (NMO) and Susac's syndrome. The excellent depiction of normal blood vessels, vessel abnormalities and infarct morphology by UHF-MRI can be utilized in vascular diseases. Detailed imaging of the hippocampus in Alzheimer's disease and the substantia nigra in Parkinson's disease as well as sensitivity to iron depositions could be valuable in neurodegenerative diseases. Current UHF-MRI studies still suffer from small sample sizes, selection bias or propensity to image artefacts. In addition, the increasing clinical relevance of 3T-MRI has not been sufficiently appreciated in previous studies. Although UHF-MRI is only available at a small number of medical research centers it could provide a high-end diagnostic tool for healthcare optimization in the foreseeable future. The potential of UHF-MRI still has to be carefully validated by profound prospective research to define its place in future medicine.

Impact of brain tissue filtering on neurostimulation fields: a modeling study

Electrical neurostimulation techniques, such as deep brain stimulation (DBS) and transcranial magnetic stimulation (TMS), are increasingly used in the neurosciences, e.g., for studying brain function, and for neurotherapeutics, e.g., for treating depression, epilepsy, and Parkinson's disease. The characterization of electrical properties of brain tissue has guided our fundamental understanding and application of these methods, from electrophysiologic theory to clinical dosing-metrics. Nonetheless, prior computational models have primarily relied on ex-vivo impedance measurements. We recorded the in-vivo impedances of brain tissues during neurosurgical procedures and used these results to construct MRI guided computational models of TMS and DBS neurostimulatory fields and conductance-based models of neurons exposed to stimulation. We demonstrated that tissues carry neurostimulation currents through frequency dependent resistive and capacitive properties not typically accounted for by past neurostimulation modeling work. We show that these fundamental brain tissue properties can have significant effects on the neurostimulatory-fields (capacitive and resistive current composition and spatial/temporal dynamics) and neural responses (stimulation threshold, ionic currents, and membrane dynamics). These findings highlight the importance of tissue impedance properties on neurostimulation and impact our understanding of the biological mechanisms and technological potential of neurostimulatory methods.

Cognition and Hemodynamics

The relationship between cerebral hemodynamics and cognitive performance has increasingly become recognized as a major challenge in clinical practice for older adults. Both diabetes and hypertension worsen brain perfusion and are major risk factors for cerebrovascular disease, stroke and dementia. Cerebrovascular reserve has emerged as a potential biomarker for monitoring pressure-perfusion-cognition relationships. Endothelial dysfunction and inflammation, microvascular disease, and mascrovascular disease affect cerebral hemodynamics and play an important role in pathohysiology and severity of multiple medical conditions, presenting as cognitive decline in the old age. Therefore, the identification of cerebrovascular vascular reactivity as a new therapeutic target is needed for prevention of cognitive decline late in life.

Ultrahigh-field magnetic resonance imaging: the clinical potential for anatomy, pathogenesis, diagnosis, and treatment planning in brain disease

In this review, current (clinical) applications and possible future directions of ultrahigh-field (≥7 T) magnetic resonance (MR) imaging in the brain are discussed. Ultrahigh-field MR imaging can provide contrast-rich images of diverse pathologies and can be used for early diagnosis and treatment monitoring of brain disease. These images may provide increased sensitivity and specificity. Several limitations need to be overcome before worldwide clinical implementation can be commenced. Current literature regarding clinically based ultrahigh-field MR imaging is reviewed, and limitations and promises of this technique are discussed, as well as some practical considerations for the implementation in clinical practice.

3T MRI: advances in brain imaging

Since its approval by the FDA in 2000, brain MR imaging at 3.0 T has been increasingly used in clinical practice. Theoretically, the signal-to-noise ratio (SNR) of a 3T MR scanner will be double that of a 1.5 T scanner. However, the relationship between the magnetic field used and the image obtained is very complex. Today, using a 3T magnet in Neuroradiology has far more advantages than disadvantages, and the diagnostic potential of higher strength magnets for structural and vascular scans, diffusion and perfusion imaging, spectroscopy and cortical activation studies is improving. However, it is useful to have an awareness of how increasing field strength affects each of these techniques so that full advantage may be taken of them.

Stroke Imaging at 3.0 T

Stroke is a devastating disease with a complex pathophysiology. It is a major cause of death and disability in North America. To fully characterize its extent and effects, one requires numerous specialized anatomical and functional MR techniques, specifically diffusion-weighted imaging, MR angiography, and perfusion-weighted imaging. The advent of 3.0 T clinical scanners has the potential to provide higher quality information in potentially less time compared with 1.5 T stroke-specific MR imaging protocols. This article gives a brief overview of stroke, presents the principles and clinical applications of the relevant MR techniques required for diagnostic stroke imaging at high field, and discusses the advantages, challenges, and limitations of 3.0 T imaging as they relate to stroke.

High-resolution ultrahigh-field MRI of stroke

BACKGROUND

Ultrahigh-field MRI at 8 T offers unprecedented resolution for imaging brain structures and microvasculature.

OBJECTIVE

The aim of this study is to apply high-resolution MRI for stroke imaging and to characterize findings at 1.5 and 8 T.

METHODS

Seventeen subjects with minor ischemic infarcts were studied using T2-weighted gradient echo (GE) and rapid acquisition with relaxation enhancement (RARE) images at 8 T with resolution up to 200 microm. In 10 subjects, T1- and T2-weighted fast spin echo (FSE) and fluid-attenuated inversion recovery (FLAIR) images were also acquired at 1.5-T MRI.

RESULTS

The 8-T images showed infarcts as sharply demarcated areas of high-signal intensity (n=21) and revealed more infarctions than 1.5-T images (n=14) (P<.003). The low-signal intensity areas that surrounded infarctions were suggestive of hemosiderin deposits. The 8-T characteristics of microvessels terminating within the infractions were distinct from normal vasculature. The 8-T images revealed an angioma at the site of a second stroke, not apparent on 1.5-T images.

CONCLUSIONS

Ultrahigh-field MRI at 8 T is feasible for stroke imaging. The 8-T MRI visualized infarcts and microvasculature with high resolution, revealing infarcts and vascular pathologies that were not apparent at 1.5 T.

New developments in magnetic resonance imaging of the brain

Magnetic resonance imaging (MRI) continues to have a large impact on the diagnosis and management of a number of diseases, especially diseases associated with brain injury. The strengths of MRI are the unique contrast that can be obtained, and the fact that it is not harmful and that it can be readily applied to human and animal models. The past decade has seen development of functional MRI techniques that measure aspects of hemodynamics and water diffusion that are playing an important role. Indeed, these techniques are having a major impact on management of brain injury. The development of MRI continues at a rapid pace and a renewed push to increased spatial and temporal resolution will extend the applicability of anatomical and functional MRI. Increased interest in molecular imaging using MRI is increasing the number of processes that can be imaged in the brain. This work reviews some new developments that are being made in anatomical, functional, and molecular MRI of the brain, with comments about usefulness for work in the area of neuroprotection.

Acute and Subacute Intracerebral Hemorrhages: Comparison of MR Imaging at 1.5 and 3.0 T—Initial Experience

PURPOSE

To assess and describe the appearance of intracerebral hemorrhage (ICH) at 3.0-T magnetic resonance (MR) imaging as compared with the appearance of this lesion type at 1.5-T MR imaging.

MATERIALS AND METHODS

Sixteen patients with 21 parenchymal ICHs were examined. ICHs were classified as hyperacute, acute, early subacute, late subacute, or chronic. Patients underwent 1.5- and 3.0-T MR imaging with T2-weighted fast spin-echo, fluid-attenuated inversion-recovery (FLAIR), and T1-weighted spin-echo (1.5-T) and gradient-echo (3.0-T) sequences within 4 hours of each other. The central (ie, core) and peripheral (ie, body) parts of the ICHs were analyzed quantitatively by using contrast-to-noise ratio (CNR) calculations derived from signal intensity (SI) measurements; these values were statistically evaluated by using the Mann-Whitney U test. Two readers qualitatively determined SIs of the cores and bodies of the ICHs, degrees of apparent susceptibility artifacts, and lesion ages. The chi(2) test was used to determine statistically significant differences.

RESULTS

With the exception of the bodies of late subacute ICHs at 3.0-T T2-weighted imaging, which had increased positive CNRs and SI scores (P </=.05), all parts of the ICHs at all stages showed increased negative CNRs and SI scores at 3.0-T FLAIR and T2-weighted imaging, as compared with these values at 1.5 T (P </=.05). No significant CNR or SI score differences at any ICH stage were observed between 1.5-T spin-echo and 3.0-T gradient-echo T1-weighted imaging (P >.05). With the exception of minor susceptibility artifacts seen in acute and early subacute ICHs at 3.0-T T1-weighted gradient-echo imaging, no susceptibility artifacts were noticed. The ages of most lesions were identified correctly without significant differences between the two field strengths (P >.05), with the exception of the ages of acute ICHs, which were occasionally misinterpreted as early subacute lesions at 3.0 T.

CONCLUSION

At 3.0 T, all parts of acute and early subacute ICHs had significantly increased hypointensity on FLAIR and T2-weighted MR images as compared with the SIs of these lesions at 1.5 T. However, 1.5- and 3.0-T MR images were equivalent in the determination of acute to late subacute ICHs.

Venous cavernoma at 8 Tesla MRI

Cavernous angiomas or cavernomas are vascular malformations, which may be associated with risk of bleeding episodes. We present a case report comparing high resolution 8 Tesla gradient echo (GE) imaging with routine fast spin echo (FSE) at 1.5 Tesla in a patient with venous cavernoma. A 55-year-old male with a history of hemorrhagic stroke was studied using high-resolution 8 Tesla magnetic resonance imaging (MRI) system, which revealed venous cavernoma (9 x 8.6 mm) in the left parietal region and visualized adjacent microvascular supply. Signal loss was prominent in the cavernoma region compared to surrounding brain tissue, and signal intensity declined by factor 7.3 +/- 2.4 (679 +/- 62%) on GE images at 8 Tesla. Cavernoma was not apparent on routine T(2)-weighted FSE images at 1.5 Tesla MRI. This case report indicates that GE images at 8 Tesla can be useful for evaluation of vascular pathologies and microvasculature.

Comparison of 1.5 and 8 tesla high-resolution magnetic resonance imaging of lacunar infarcts

PURPOSE

We present a case report comparing 1.5 fast spin-echo (FSE) and high-resolution 8 Tesla (T) gradient echo (GE) MRI of a patient with multiple lacunar infarcts.

METHODS

A 51-year-old man with a history of previous lacunar infarctions was studied with two-dimensional Fourier transform axial 8 T GE MRI using the following parameters: 3 mm thick slices skip 3 mm, flip-angle approximately 20 degrees, TR 800 milliseconds, TE 12 milliseconds, 1024 x 1024 matrix, field of view (FOV) 20 cm, and bandwidth 50 kHz. These images were then compared with routine clinical 1.5 T T2-weighted FSE images with 5 mm thick sections, 256 x 256, FOV 20, TR 5650, TE 102, and 16 echo train length.

RESULTS

The majority of the infarctions were seen as areas of high signal intensity on both the 1.5 and 8 T images. They were seen in the corona radiata or the basal ganglia. More lesions were seen on the 8 T images. Low intensity signal was best demonstrated on the 8 T images at segments of the periphery of a few of the larger infarcts. There were a few small punctate low signal intensity regions localized at the termination of some of the microvessels on the 8 T images only. The foci of decreased signal intensity in regions of chronic hemorrhage appeared larger on the 8 T images compared with the 1.5 T images. The 8 T images demonstrated direct visualization of many small vessels, primarily in the deep white matter, which were not visible on the 1.5 T images. On the 8 T images, some of the infarcts appeared to be located between the medullary veins of the deep white matter.

CONCLUSION

This case report indicates that GE 8 T images demonstrate more infarctions compared with the FSE 1.5 T images. It is possible to simultaneously identify the microvessels of the brain, small foci of hemorrhage, and lacunar infarctions using 8 T MRI.